Table 1.
Baseline characteristics of patients in HPV16-positive cohort
| Characteristic | Value |
|---|---|
| Total number of patients | 9 |
| Age, years median (range) | 53 (43–68) |
| Gender | |
| Male | 9 |
| Female | 0 |
| Race | |
| Black | 1 (11 %) |
| White | 8 (89 %) |
| Other | 0 |
| Performance status | |
| Median | 1 |
| Range | 0–1 |
| Primary site | |
| Oral | 0 |
| Oropharynx | 8 (89 %) |
| Hypopharynx | 0 |
| Larynx | 1 (11 %) |
| Nasopharynx | 0 |
| Nasal/paranasal | 0 |
| Disease at enrollment | |
| Locoregional recurrence only | 2 (22 %) |
| Metastatic disease | 7 (78 %) |
| Sites of metastatic disease | |
| Lung | 5 |
| Bone | 2 |
| Liver | 1 |
| Other | 1 (retroperitoneum) |
| Number of prior chemotherapy regimens | |
| 0 | 2 (22 %) |
| 1 | 3 (33 %) |
| 2 | 2 (22 %) |
| 3+ | 2 (22 %) |